Home Data Calendar Blog

IMNM

Tables

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Common Stock Value 0.010.000.000.000.00
Weighted Average Number Of Diluted Shares Outstanding 51.54NANA12.2012.18
Weighted Average Number Of Shares Outstanding Basic 51.54NA12.2012.2012.18
Earnings Per Share Basic -2.51-4.22-0.36-0.46-0.35
Earnings Per Share Diluted -2.51-4.22-0.36-0.46-0.35

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Revenue From Contract With Customer Excluding Assessed Tax 1.033.833.564.262.36
Revenues 1.033.833.564.262.36
Operating Expenses 133.3398.488.2010.046.83
Research And Development Expense 15.379.643.825.723.91
General And Administrative Expense 6.008.044.384.322.92
Operating Income Loss -132.30-94.65-4.63-5.77-4.47
Interest Income Expense Net 2.812.020.290.220.20
Allocated Share Based Compensation Expense 2.162.881.081.031.22
Profit Loss -129.49-92.63-4.34-5.56-4.27
Net Income Loss -129.49-92.63-4.34-5.56-4.27
Comprehensive Income Net Of Tax -129.51NANANA-4.27
Net Income Loss Available To Common Stockholders Basic -129.49-92.63-4.34NA-4.27

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Assets 319.75148.5493.1641.4448.11
Liabilities 34.1828.6687.0832.1034.25
Liabilities And Stockholders Equity 319.75148.5493.1641.4448.11
Stockholders Equity 285.57119.886.089.3413.86

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Assets Current 313.33144.7091.4139.5346.54
Cash And Cash Equivalents At Carrying Value 269.7298.6890.6438.4244.42
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 269.8298.7890.7438.5244.52
Prepaid Expense And Other Assets Current 3.626.560.771.112.11

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Property Plant And Equipment Net 4.302.071.171.200.92
Other Assets Noncurrent 0.570.10NANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Liabilities Current 30.7721.8323.1126.3924.83
Accounts Payable Current 7.183.312.793.703.31
Other Accrued Liabilities Current 0.420.310.250.490.24
Other Liabilities Current 0.060.200.54NANA
Contract With Customer Liability Current 12.7410.4916.9617.6718.21

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Deferred Income Tax Liabilities Net NA0.38NANANA
Other Liabilities Noncurrent NA1.340.12NANA
Operating Lease Liability Noncurrent 1.211.34NANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Stockholders Equity 285.57119.886.089.3413.86
Common Stock Value 0.010.000.000.000.00
Additional Paid In Capital 637.86342.66136.25135.16134.13
Retained Earnings Accumulated Deficit -352.30-222.81-130.17-125.83-120.27
Accumulated Other Comprehensive Income Loss Net Of Tax 0.000.02NANANA
Stock Issued During Period Value New Issues NA0.000.000.000.22
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 2.162.881.071.001.20

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Net Cash Provided By Used In Operating Activities -11.17-17.46-8.61-5.6724.17
Net Cash Provided By Used In Investing Activities -37.23-30.00-0.04-0.34-0.11
Net Cash Provided By Used In Financing Activities 219.4455.5060.880.000.03

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Net Cash Provided By Used In Operating Activities -11.17-17.46-8.61-5.6724.17
Net Income Loss -129.49-92.63-4.34-5.56-4.27
Profit Loss -129.49-92.63-4.34-5.56-4.27
Depreciation Depletion And Amortization 0.160.150.110.100.09
Increase Decrease In Accounts Payable 2.40-0.68-1.210.590.69
Share Based Compensation 2.162.881.081.031.22

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Net Cash Provided By Used In Investing Activities -37.23-30.00-0.04-0.34-0.11
Payments To Acquire Property Plant And Equipment 2.160.350.040.340.11

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Net Cash Provided By Used In Financing Activities 219.4455.5060.880.000.03

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Revenues 1.033.833.564.262.36
Collaboration Agreement With Abbvie 1.003.803.604.302.40
Revenue From Contract With Customer Excluding Assessed Tax 1.033.833.564.262.36
Collaboration Agreement With Abbvie 1.003.803.604.302.40

Plots across concepts


IncomeStatement
Operating Income Loss
Balance Sheet
Operating Lease Right Of Use Asset
Assets
Operating Lease Right Of Use Asset
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Other Assets Noncurrent
Liabilities
Liabilities Current
Current Liabilities
Other Liabilities Current
Noncurrent Liabilities
Deferred Income Tax Liabilities Net
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
Shares
Weighted Average Number Of Diluted Shares Outstanding

Line plots across dimensions of each concept